HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.

Marco Vitale(Vita-Salute San Raffaele University), Soldano Ferrone(Massachusetts General Hospital), Moris Cadei, Daniel J. Hicklin(C4 Therapeutics (United States)), Rita Rezzani(University of Brescia), Luigi Fabrizio Rodella(University of Brescia), P Grigolato, Giorgio Zauli(King Khaled Eye Specialist Hospital)
PubMed
February 15, 1998
Cited by 174


Related Papers